Physician profile
Rick Mishler
NPI 1629071303
$4,444.17
in general payments reported to CMS, 2019-2025
12 companies · $307 in 2025
The $307 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,349 · 2020: $356 · 2021: $929 · 2022: $51.31 · 2023: $297 · 2024: $155 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $3,338.64 | 2019-2021 | |
| Venturemed Group, INC. | $563.25 | 2022-2025 | Flex Vessel Prep System |
| Bard Peripheral Vascular, INC. | $151.02 | 2020 | |
| Covidien LP | $130.91 | 2020 | |
| Nxstage Medical, INC. | $84.61 | 2023 | Liberty Select Cycler |
| Otsuka America Pharmaceutical, INC. | $40.87 | 2022-2024 | Jynarque |
| Vifor Pharma, INC. | $34.36 | 2021-2023 | Korsuva, Veltassa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.40 | 2024 | Jardiance |
| Fresenius USA Marketing, INC. | $23.72 | 2024 | Velphoro |
| Mallinckrodt Hospital Products INC. | $19.05 | 2025 | Acthar |
| Daiichi Sankyo INC. | $15.00 | 2023 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rick Mishler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.